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Studies over the past decade have helped to decipher molecular networks dependent
on Toll-like receptor (TLR) signaling, in mycobacteria-infected macrophages. Stimulation
of TLRs by mycobacteria and their antigenic components rapidly induces intracellular
signaling cascades involved in the activation of nuclear factor-κB and mitogen-activated
protein kinase pathways, which play important roles in orchestrating proinflammatory
responses and innate defense through generation of a variety of antimicrobial effector
molecules. Recent studies have provided evidence that mycobacterial TLR-signaling cross
talks with other intracellular antimicrobial innate pathways, the autophagy process and
functional vitamin D receptor (VDR) signaling. In this article we describe recent advances
in the recognition, responses, and regulation of mycobacterial signaling through TLRs.
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INTRODUCTION
Tuberculosis remains a serious health problem worldwide, caus-
ing an alarming two million deaths annually (WHO, 2010).
One-third of the global population is latently infected with
Mycobacterium tuberculosis (Mtb). In this state, healthy immune-
competent individuals are able to combat infection by mounting
of an effective immune response (Huynh et al., 2011). When the
immune system is compromised, the bacteria are capable of repli-
cating, disseminating, and causing a progressive infectious disease
(Huynh et al., 2011). Thus, appropriate and efficient mounting
of host immune responses are required for controlling tuber-
culosis infection. Protective immunity to mycobacteria mainly
requires an interplay between innate immune responses and
Th1-dependent cellular immune responses, which cooperatively
contribute to clear the major human pathogen, Mtb (Zuñiga
et al., 2012).
During infection of macrophages, Mtb and its components
encounters innate immunity, which operates through a vari-
ety of germline-encoded pattern recognition receptors including
Toll-like receptors (TLRs) for recognition of various molecu-
lar patterns of mycobacteria (Jo et al., 2007; Natarajan et al.,
2011). The innate immune response triggered by engage-
ment of TLRs, involves recruitment of cytoplasmic adap-
tor proteins and intracellular signaling molecules resulting in
phagosome maturation and the synthesis of pro-inflammatory
cytokines (Sundaramurthy and Pieters, 2007; Natarajan et al.,
2011). Antimicrobial responses through TLR-dependent trigger-
ing of intracellular signaling cascades, involves the activation
of nuclear factor (NF)-κB in murine macrophages and vitamin
D receptor (VDR) signaling in human monocytes/macrophages
(Sundaramurthy and Pieters, 2007; Jo, 2010; Yuk et al.,
2012). Recent studies have also highlighted that the autophagy
pathway is critically involved in degradation/elimination of
intracellular microbes, including Mtb (Deretic, 2012; Mintern
and Villadangos, 2012). Pathogenic mycobacteria utilize a unique
strategy to survive within macrophages. They have developed
tactics to escape from host autophagic process. They also
expose multiple ligands that are recognized by host TLRs. An
understanding of the complex mechanisms involved in this
hide-and-seek game (host-pathogen interaction) is required
for development of novel intervention strategies to combat
tuberculosis.
In this Review, we focus on emerging data showing that
mycobacteria and their ligands activate or modulate TLR signal-
ing pathways. Specifically, we discuss the mechanisms by which
TLR signaling regulates the initiation and progression of innate
immune responses, and eradication of intracellular mycobacteria
through cooperation with autophagy andVDR signaling pathway.
OVERVIEW OF TLRs IN MYCOBACTERIAL INFECTION
Mtb primarily invades the lung alveoli via inhalation and alve-
olar macrophages are the principal cell types infected by this
pathogen (Huynh et al., 2011). When Mtb are internalized by
alveolar macrophages or other innate cells, they encounter a vari-
ety of intracellular innate receptors including TLRs. So far, there
is evidence that mycobacterial components are engaged by TLR2
in association with TLR1/TLR6, by TLR4, or by TLR9 (which rec-
ognizes Mtb DNA) (Doherty and Arditi, 2004; Jo et al., 2007).
Earlier in vivo studies showed somewhat discordant results in sus-
ceptibility of mice deficient in several TLR-related genes, includ-
ing TLR2, TLR4, TLR6, or MyD88, in Mtb infection (Doherty
and Arditi, 2004; Quesniaux et al., 2004). It was also reported that
TLR2/4/9-deficient mice have no apparent difference in activation
of antigen-specific T cells, and production of pro-inflammatory
cytokines and interferon (IFN)-γ, when compared with wild-type
mice (Hölscher et al., 2008). The controversial results might be
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due to differences in Mtb strains used, doses of infection, differ-
ences in genetic backgrounds, etc. The detailed description about
the in vivo role of TLRs in mycobacterial infection is summa-
rized in excellent earlier reviews by Stenger and Modiln (2002);
Doherty and Arditi (2004); andQuesniaux et al. (2004). However,
the exact roles and regulatory mechanisms by which TLRs affect
innate immunity and antimicrobial responses have not been fully
characterized.
Numerous studies have revealed that TLR2 is involved in the
innate recognition and responses in innate immune cells such
as macrophages and dendritic cells of a variety of mycobacte-
rial cell wall antigens including 19-kDamycobacterial lipoprotein,
glycolipids like lipoarabinomannan (LAM), LM, 38-kDa antigen,
LprG lipoprotein, phosphatidylinositol mannoside (PIM), tria-
cylated (TLR2/TLR1), or diacylated (TLR2/TLR6) lipoproteins
[reviewed in Jo et al. (2007); Kleinnijenhuis et al. (2011)]. TLR4
is activated by heat shock protein 60/65 and 38-kDa antigen,
whereas TLR9 recognizes unmethylated CpG motifs of mycobac-
terial DNA [reviewed by Jo et al. (2007); Kleinnijenhuis et al.
(2011)]. Stimulation of TLRs by mycobacterial ligands leads to an
initiation of intracellular signaling cascades culminating in proin-
flammatory cytokine generation in macrophages and dendritic
cells through activation of NF-κB and MAPK pathways (Jo et al.,
2007, summarized in Figure 1). Along with canonical NF-κB and
MAPK-dependent signaling, it may also be noted that the tran-
scription factor nuclear factor of activated T cells 5 (NFAT5) can
be activated by TLR signaling induced by Mtb stimulation, and
the co-infection of HIV-1 in tuberculosis accelerates an increase
of viral load through expression of NFAT5 (Ranjbar et al., 2012).
Recent reports have highlighted that other cells such as alveolar
epithelial cells play an important role in innate defense to produce
the chemokine CCL2 and also in the pathogenesis of mycobacte-
rial infection (Chuquimia et al., 2012). Additionally, mast cells
are activated by mycobacterial LAM to induce the generation of
cysteinyl leukotriene through TLR2-NF-κB-dependent signaling
(Ba¸bolewska et al., 2012). Together, these studies suggest that
TLRs have a crucial role in the host immune responses against
mycobacterial infection and that they are involved in not only
immune cells but also other cells. These findings have been sum-
marized in Figure 1. In this context, it is pertinent to note that
while, to the best of our knowledge, there is no detailed report
on the temporal dynamics of NF-κB activation during infection,
our (Basu laboratory) unpublished observations from ex vivo
experiments using Mtb-infected macrophages, indicate that the
upregulation of NF-κB dampening molecules such as TNFAIP3
(A20) occurs as early as 24 h post-infection. It is obvious that Mtb
elicits inflammation-dampening signals in macrophages which
would favor its survival.
FIGURE 1 | A schematic model for TLRs activation by diverse
mycobacterial antigens. TLRs are involved in the innate recognition and
responses in innate immune cells to numerous mycobacterial antigens.
Some mycobacterial antigens including LpqH, lipoarabinomannan (LAM),
lipomannan (LM), 38-kDa antigen, LprG, LprA, PhoS1, trehalose dimycolate
(TDM), phosphatidylinositol mannoside (PIM) activate TLR2/1 or 6, whereas
TLR4 recognizes heat shock protein (HSP) 60/65 and 38-kDa antigen. TLR
activation by mycobacterial antigens leads an intracellular signaling pathway
that culminates in the production of proinflammatory in macrophages and
dendritic cells through MAPK and NF-κB pathways.
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TLRs SIGNALING BY MYCOBACTERIAL COMPONENTS
Many previous studies have reported that mycobacterial compo-
nents are involved in innate recognition and responses through
TLR signaling (Basu et al., 2007; Pathak et al., 2009; Bansal
et al., 2010, 2011; Heo et al., 2011; Byun et al., 2012a,b).
Antigens of the PE_PGRS family, namely, PE_PGRS 17 (Rv0978c)
and PE_PGRS 11 (Rv0754), recognize TLR2 to induce matura-
tion and activation of human dendritic cells, and enhance the
ability of dendritic cells to stimulate CD4(+) T cells (Bansal
et al., 2010). These PE_PGRS proteins activate dendritic cells
through ERK1/2 and p38 MAPK signaling pathways. Basu
et al. have shown that PE_PGRS 33 signals through TLR2 to
release TNF-α to induce apoptosis of macrophages (Basu et al.,
2007).
Other Mtb proteins have been shown to influence dendritic
cell function. Rv0462 (lipoamide dehydrogenase C), Rv0315,
and Rv0577 (Mtb-restricted secretory protein involved in the
methylglyoxal detoxification pathway) induce dendritic cell mat-
uration and activation leading to increased expression of cos-
timulatory molecules (CD80, CD86, and class II MHC) and
proinflammatory cytokines (TNF-α, IL-1β, IL-6, and IL-12),
and potentiate the Th1 immune response (Heo et al., 2011;
Byun et al., 2012a,b). These findings have been summarized in
Figure 2.
Yet another effecter of proinflammatory cytokine produc-
tion is trehalose dimycolate (TDM). TDM has been reported
to be tethered to several receptors, including TLR2, the class
A scavenger receptor MARCO, Fc receptor-γ (FcRγ), and
macrophage-inducible C-type lectin (Mincle) (Bowdish et al.,
2009; Ishikawa et al., 2009; Werninghaus et al., 2009). TDM
triggers MARCO/TLR2/CD14-dependent signaling to produce
proinflammatory cytokines (Bowdish et al., 2009). In addition
to TLR2-dependent signaling, TDMs also activate macrophages
and dendritic cells via FcRγ-Syk-Card9 pathway (Werninghaus
et al., 2009). Mincle, which is one of the C-type lectin recep-
tors expressed in macrophages subjected to several types of stress
(Matsumoto et al., 1999), is an essential receptor for TDM-
dependent inflammatory responses, nitric oxide synthesis, and
granuloma formation (Ishikawa et al., 2009). TDM receptors are
associated with partial protection against Mtb infection (Bowdish
et al., 2009; Ishikawa et al., 2009; Werninghaus et al., 2009).
Recent work by Bansal et al. (2011) suggests that upon infec-
tion with M. bovis bacille Calmette-Guérin (BCG), TLR2 signal-
ing activates Wnt-β-catenin signaling. The authors suggest that
TLR2 integrates Wnt-β-catenin signaling to modulate a battery
of genes associated with T(Reg) cell lineage commitment. At
low MOIs, Mtb-triggered macrophage apoptosis depends on a
TLR2 signaling cascade associated with ASK1/p38 MAPK- and
FIGURE 2 | A schematic diagram for mechanisms of dendritic cell
maturation/activation to stimulate T cells by mycobacterial antigens.
PE_PGRS proteins activate dendritic cells through TLR2-MAPK-NF-κB
signaling pathways. PE_PGRS 33-induced TNF-α by dendritic cells induces
apoptosis in macrophages. Others (e.g., Rv0462, Rv0315, Rv0577, and
PE_PGRS 17/11) increase expression of costimulatory molecules (CD80,
CD86, and class II MHC) and proinflammatory cytokines (TNF-α, IL-1β, IL-6,
and IL-12), leading to Th1 immune responses.
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c-Abl-dependent phosphorylation of c-FLIP and its degradation,
leading to caspase 8 activation (Kundu et al., 2009).
TLR-dependent NF-κB signaling and MAPK pathways con-
tribute to antimycobacterial innate immunity through secretion
of antibacterial effector molecules, cytokines, and chemokines,
thus recruiting various immune cells to the site of infection (Jo
et al., 2007; Jo, 2010; Huynh et al., 2011; Kleinnijenhuis et al.,
2011). In contrast, Mtb-mediated TLR2 signaling is associated
with generation of an environment favoring the survival of Mtb
in macrophages (Yoshida et al., 2009). Together, TLR signaling in
mycobacterial infection acts as a double-edged sword regulating
a delicate balance in host innate and inflammatory responses to
determine disease outcome.
HUMAN TLR POLYMORPHISMAND MYCOBACTERIAL
INFECTION
Human genetic polymorphisms of TLRs have a role in regulating
innate recognition of microbes and in determining susceptibil-
ity to mycobacterial infection. The relationship between TLR
polymorphisms, disease susceptibility, and innate immune activ-
ities against mycobacteria has been described in several reviews
(Texereau et al., 2005; Lykouras et al., 2008; Kleinnijenhuis et al.,
2011). Here we describe the recent data on genetic and functional
studies of TLRs in protection and pathogenesis of mycobacterial
infection. It has been reported that TLR1/6-deficient genotypes
(typified by TLR1_T1805G and TLR6_C745T), after vaccination
with M. bovis BCG, are linked with the increased production
of Th1-type T cell cytokines through regulation of monocyte
IL-10 production (Randhawa et al., 2011). Other recent stud-
ies have reported that rs352139, an SNP located in the intron of
TLR9 is associated with tuberculosis susceptibility in Indonesian
and Vietnamese populations (Kobayashi et al., 2012). It has also
been reported that TLR8 polymorphisms are associated with pul-
monary tuberculosis susceptibility in males (Davila et al., 2008).
Interestingly, TLR8 transcriptional levels are increased in patients
at the early phase of infection and TLR8 protein expression is
increased in macrophages after M. bovis BCG infection (Davila
et al., 2008).
Previously, it was shown that human TLR1 deficiency is linked
with impaired mycobacterial innate immune signaling and sus-
ceptibility to leprosy (Misch et al., 2008). Recent studies have
shown that TLR chaperones, PRAT4A, and PRAT4B are impor-
tant regulators in TLR1 trafficking to the cell surface and are
also regulated by IFN-γ (Hart and Tappiung, 2012). Furthermore,
there is an inverse correlation between Euro-American lineage
of Mtb and extra-pulmonary dissemination, suggesting that a
link between interaction between host and mycobacterial geno-
types and the clinical progression of tuberculosis (Caws et al.,
2008). Future studies are warranted to define the exact relation-
ship between host and bacterial genotype and disease phenotype
using clinical isolates.
CROSS TALK BETWEEN TLR, AUTOPHAGY, AND VITAMIN D
SIGNALING PATHWAYS
Several other innate immune pathways are closely linked with
the TLR signaling pathway, thus cooperatively defining the innate
immune response which enables clearance of mycobacteria inside
cells. Activation of autophagy has a critical effector role in innate
immune responses such as enhancement of phagosomal matura-
tion and coordination of the innate and adaptive immune systems
(Deretic, 2009, 2012). It is known that a variety of pathogen-
or danger-associated molecular patterns and pattern-recognition
receptor signaling are closely associated with autophagy activa-
tion (Xu et al., 2007; Delgado et al., 2008; Fabri et al., 2011a;
Deretic, 2012). Therefore, it is not surprising that TLR signal-
ing pathways triggered by engagement of mycobacterial antigens
lead to activation of autophagy (Shin et al., 2010). The activa-
tion of autophagy influences the antigen-presenting capacity of
the immunodominant mycobacterial antigen Ag85B by antigen-
presenting cells (Jagannath et al., 2009), as well as the produc-
tion of antimicrobial proteins and pro-inflammatory cytokines
(Yuk et al., 2009; Shin et al., 2010), thereby influencing vac-
cine efficacy and host immune defense during mycobacterial
infection.
Recent studies have uncovered the interplay of vitamin
D-dependent antimicrobial responses and autophagy pathways
in the activation of host defense against mycobacterial infec-
tion (Yuk et al., 2009; Jo, 2010; Shin et al., 2010; Fabri
et al., 2011a). Activation of TLR signaling in human mono-
cytes/macrophages has been shown to lead to the induction
of the antimicrobial peptide cathelicidin, which is critically
involved in antimicrobial responses against Mtb (Liu et al.,
2006, 2007; Yang et al., 2009). Physiological concentrations of
1,25D3 were found to be enough to induce the production
of the human cathelicidin and autophagic flux, thereby acti-
vating antimicrobial activities against Mtb and also inhibiting
HIV replication in cells co-infected with Mtb and HIV (Yuk
et al., 2009; Campbell and Spector, 2012). Moreover, cathelicidin
plays a dual role in vitamin D-induced autophagy activation in
human monocytes/macrophages, acting both as a critical effec-
tor of antimicrobial responses against Mtb and as a mediator
of the autophagy pathway through enhancement of autophagic
flux and the induction of autophagy-related genes (Yuk et al.,
2009; Campbell and Spector, 2012). Importantly, in human
macrophages cultured with vitamin D-sufficient sera, IFN-γ pro-
duction by Th1 cells as well as stimulation of TLR2/1, turn on
antimicrobial activity through antimicrobial peptide expression,
autophagy activation, and phagosome-lysosome fusion (Fabri
et al., 2011b). These findings provide insights into how vitamin
D-dependent signaling triggers antimicrobial activity by activat-
ing autophagy and regulating both innate and adaptive immune
responses.
The impact of host autophagy on phagosome maturation and
Mtb killing gives rise to the idea that compounds that activate
or modulate the autophagy pathway, could potentially enhance
antimicrobial activities against Mtb infection (Gutierrez et al.,
2004; Singh et al., 2006; Fabri et al., 2011a; Kim et al., 2012; Lam
et al., 2012; Zullo and Lee, 2012). Recent studies have shown that
the prevalent anti-TB drugs isoniazid and pyrazinamide promote
autophagy activation. This plays an important role in success-
ful antimicrobial responses during therapy against mycobacterial
infection in vivo and in vitro (Kim et al., 2012). Lam et al.
also showed that the antiprotozoal drug nitazoxanide stimulates
autophagy induction and mTORC1 inhibition, and inhibits Mtb
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proliferation in human monocytes and monocytic cells (Lam
et al., 2012).
CONCLUDING REMARKS
Developing vaccines and chemotherapeutic agents is the
cornerstone of the successful management of tuberculosis.
Understanding the molecular mechanisms of specific interac-
tions of Mtb with its host should augment efforts in both these
areas. Immune modulation as a strategy to combat mycobac-
terial infection remains underexplored. This review brings to
light how mycobacterial modulins signaling through TLRs, con-
tribute either to an effective host immune response or to
immune evasion by the pathogen. Targeting those modulins that
facilitate immune evasion, or exploiting those that facilitate a
robust innate and adaptive immune response, could offer new
avenues for controlling infection. The review also brings forth the
attractive possibility of developing therapeutics designed to aug-
ment autophagy as a means of restricting mycobacterial survival
and combating infection.
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